NextCure, Inc. (NXTC) has 20 known insider and institutional holders on record. The largest holder is Sofinnova Venture Partners IX, L.P. with 2,671,856 shares. Other notable holders include Simcere Zaiming, Inc. and Langermann Sol.
Over the last 12 months, insiders have made 13 transactions in NXTC stock — 12 buys (valued at $1.13M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
NXTC Insider Ownership
Top Holder
Sofinnova Venture Partners IX, L.P.
2,671,856 shares
Buys (12 mo)
12
$1.13M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Sofinnova Venture Partners Ix, L.p. |
10 Percent Owner |
2,671,856 |
2019-11-19 |
|
| 2 |
Simcere Zaiming, Inc. |
10 Percent Owner |
338,636 |
2025-08-19 |
|
| 3 |
Langermann Sol |
Chief Scientific Officer |
117,375 |
2025-02-03 |
|
| 4 |
Myint Han |
Chief Medical Officer |
93,900 |
2024-04-02 |
|
| 5 |
Bingham James B. |
Chief Development Officer |
78,200 |
2020-03-03 |
|
| 6 |
Liu Linda |
Officer |
65,600 |
2022-02-02 |
|
| 7 |
Richman Michael |
President & CEO |
38,190 |
2026-02-03 |
|
| 8 |
Heller Kevin N. |
Chief Medical Officer |
38,119 |
2020-07-16 |
|
| 9 |
Kabakoff David S |
Director |
28,050 |
2025-06-24 |
|
| 10 |
Shannon Timothy M |
Director |
22,000 |
2019-06-17 |
|
| 11 |
Borgman Anne Elizabeth |
Director |
18,700 |
2025-06-24 |
|
| 12 |
Houston John G |
Director |
18,700 |
2025-06-24 |
|
| 13 |
Feigal Ellen |
Director |
18,700 |
2025-06-24 |
|
| 14 |
Webster Stephen W |
Director |
18,700 |
2025-06-24 |
|
| 15 |
Jones Elaine V |
Director |
18,700 |
2025-06-24 |
|
| 16 |
Guha Udayan |
Chief Medical Officer |
14,670 |
2026-02-03 |
|
| 17 |
Mayer Timothy |
Chief Operating Officer |
14,670 |
2026-02-03 |
|
| 18 |
Cobourn Steven P. |
Chief Financial Officer |
14,670 |
2026-02-03 |
|
| 19 |
Li Judith |
Director |
14,250 |
2020-06-15 |
|
| 20 |
Khuong Chau Quang |
Director |
14,250 |
2023-06-23 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-01-30 |
Guha Udayan |
Chief Medical Officer |
RSU Award |
14,670 |
$10.85 |
$159.17K |
| 2026-01-30 |
Shaw Kevin G. |
Sr VP, General Counsel |
RSU Award |
8,270 |
$10.85 |
$89.73K |
| 2026-01-30 |
Kundu Sourav |
Sr VP, Dev. & Mfg. |
RSU Award |
8,270 |
$10.85 |
$89.73K |
| 2026-01-30 |
Mayer Timothy |
Chief Operating Officer |
RSU Award |
14,670 |
$10.85 |
$159.17K |
| 2026-01-30 |
Cobourn Steven P. |
Chief Financial Officer |
RSU Award |
14,670 |
$10.85 |
$159.17K |
| 2026-01-30 |
Richman Michael |
President & CEO |
RSU Award |
38,190 |
$10.85 |
$414.36K |
| 2025-06-20 |
Simcere Zaiming, Inc. |
10 Percent Owner |
Unknown |
- |
- |
- |
| 2025-06-20 |
Borgman Anne Elizabeth |
Director |
RSU Award |
18,700 |
$0.47 |
$8.79K |
| 2025-06-20 |
Feigal Ellen |
Director |
RSU Award |
18,700 |
$0.47 |
$8.79K |
| 2025-06-20 |
Houston John G |
Director |
RSU Award |
18,700 |
$0.47 |
$8.79K |
| 2025-06-20 |
Webster Stephen W |
Director |
RSU Award |
18,700 |
$0.47 |
$8.79K |
| 2025-06-20 |
Jones Elaine V |
Director |
RSU Award |
18,700 |
$0.47 |
$8.79K |
| 2025-06-20 |
Kabakoff David S |
Director |
RSU Award |
28,050 |
$0.47 |
$13.18K |